Cite
Yoshida K, Koyama E, Zai CC, et al. Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review. Can J Psychiatry. 2020;66(12):1019-1041doi: 10.1177/0706743720971950.
Yoshida, K., Koyama, E., Zai, C. C., Beitchman, J. H., Kennedy, J. L., Lunsky, Y., Desarkar, P., & Müller, D. J. (2021). Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 66(12), 1019-1041. https://doi.org/10.1177/0706743720971950
Yoshida, Kazunari, et al. "Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review." Canadian journal of psychiatry. Revue canadienne de psychiatrie vol. 66,12 (2021): 1019-1041. doi: https://doi.org/10.1177/0706743720971950
Yoshida K, Koyama E, Zai CC, Beitchman JH, Kennedy JL, Lunsky Y, Desarkar P, Müller DJ. Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review. Can J Psychiatry. 2021 Dec;66(12):1019-1041. doi: 10.1177/0706743720971950. Epub 2020 Nov 23. PMID: 33222504; PMCID: PMC8689451.
Copy
Download .nbib